Scimago Journal & Country Rank

Frontiers in Bioengineering and Biotechnology

Country Switzerland  - SIR icon SIR Ranking of Switzerland
28
H Index
Subject Area and CategoryBiochemistry, Genetics and Molecular Biology
Biotechnology

Chemical Engineering
Bioengineering

Engineering
Biomedical Engineering

Medicine
Histology
PublisherFrontiers Media S.A.
Publication typeJournals
ISSN22964185
Coverage2013-ongoing
Scope The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

Homepage

How to publish in this journal

Contact

Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Bioengineering2014Q3
Bioengineering2015Q1
Bioengineering2016Q1
Bioengineering2017Q1
Bioengineering2018Q1
Biomedical Engineering2014Q3
Biomedical Engineering2015Q1
Biomedical Engineering2016Q1
Biomedical Engineering2017Q1
Biomedical Engineering2018Q1
Biotechnology2014Q3
Biotechnology2015Q1
Biotechnology2016Q1
Biotechnology2017Q1
Biotechnology2018Q1
Histology2014Q3
Histology2015Q1
Histology2016Q1
Histology2017Q1
Histology2018Q1
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20140.415
20151.160
20161.347
20171.565
20181.248
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20130.000
Cites / Doc. (4 years)20141.000
Cites / Doc. (4 years)20153.457
Cites / Doc. (4 years)20163.341
Cites / Doc. (4 years)20174.101
Cites / Doc. (4 years)20184.534
Cites / Doc. (3 years)20130.000
Cites / Doc. (3 years)20141.000
Cites / Doc. (3 years)20153.457
Cites / Doc. (3 years)20163.341
Cites / Doc. (3 years)20174.114
Cites / Doc. (3 years)20184.443
Cites / Doc. (2 years)20130.000
Cites / Doc. (2 years)20141.000
Cites / Doc. (2 years)20153.457
Cites / Doc. (2 years)20163.347
Cites / Doc. (2 years)20173.970
Cites / Doc. (2 years)20184.212
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20130
Self Cites20140
Self Cites201522
Self Cites20167
Self Cites20179
Self Cites201831
Total Cites20130
Total Cites20141
Total Cites2015242
Total Cites2016822
Total Cites20171374
Total Cites20181475
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20130
External Cites per document20141.000
External Cites per document20153.143
External Cites per document20163.313
External Cites per document20174.087
External Cites per document20184.349
Cites per document20130.000
Cites per document20141.000
Cites per document20153.457
Cites per document20163.341
Cites per document20174.114
Cites per document20184.443
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
20130.00
201422.22
201531.22
201631.73
201727.78
201835.03
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20130
Non-citable documents20140
Non-citable documents20153
Non-citable documents201616
Non-citable documents201731
Non-citable documents201833
Citable documents20130
Citable documents20141
Citable documents201570
Citable documents2016246
Citable documents2017334
Citable documents2018332
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20130
Uncited documents20140
Uncited documents201515
Uncited documents201658
Uncited documents201776
Uncited documents201873
Cited documents20130
Cited documents20141
Cited documents201558
Cited documents2016204
Cited documents2017289
Cited documents2018292
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
Loading comments...

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2019. Data Source: Scopus®